IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their ...

Chronic kidney disease (CKD) is marked by the gradual loss of kidney function, which means the kidneys cannot filter waste and regulate water and acid in the blood as well as they should. Early in the ...

Panelists discuss how the IMROZ trial demonstrated improved outcomes with quadruplet therapy combining daratumumab, lenalidomide, melphalan, and prednisone in patients with transplant-ineligible newly ...

People with kidney disease may be at higher risk of anxiety and depression. But taking care of your mental health can have a positive effect on your outlook with kidney disease. Chronic kidney ...

The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.

强生达雷妥尤单抗进入“百亿美元俱乐部”几乎已无悬念之际，蓄势已久的CD38药物终于在2025年开年展现出了燎原态势。 2025年的第二周，CD38靶点 ...

In the photo, taken in Sept. 2022 and publicly released in Dec. 2024, the dunes appear surprisingly motionless. Dunes on both Mars and Earth usually migrate as wind picks up grains of sand from ...

1月10日，康诺亚宣布，就潜在同类最优的靶向CD38人源化单克隆抗体CM313与Timberlyne Therapeutics达成独家授权许可协议。 CM313是由康诺亚自主研发的靶向 ...

U.S.-based biotech builder Mountainfield Venture Partners and China’s Keymed Biosciences have launched a new company armed with $180 million in series A funds and a clinical-stage CD38-targeting ...

赛诺菲今日宣布，旗下抗CD38单抗赛可益 ® （艾沙妥昔单抗注射液）获得国家药品监督管理局（NMPA）批准，用于与泊马度胺和地塞米松联合用药 ...

中国网财经1月9日讯 赛诺菲今日宣布，旗下抗CD38单抗赛可益(艾沙妥昔单抗注射液)获得国家药品监督管理局(NMPA)批准，用于与泊马度胺和地塞米松 ...